Eric Van Quaquebeke
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents 3
- Biomaterials top 5%
- Phytochemistry and Bioactive Compounds 6
- Pharmacology top 5%
- Molecular Biology top 10%
- Phytochemical Studies and Bioactivities 7
- Cancer therapeutics and mechanisms 5
- Steroid Chemistry and Biochemistry 4
- Ion Transport and Channel Regulation 3
- Natural product bioactivities and synthesis 3
- Organic Chemistry top 10%
- Synthesis and biological activity 2
- Co-authors
- Róbert KissFrancis DarroTatjana MijatovicJanique DewelleOlivier DebeirBruno DelestMohamed El YazidiVéronique Mathieu
- Cited by
- ToxicologyBiomaterialsPharmacology
- Journals
- Cancer Research (5 papers)Molecular Cancer Therapeutics (4 papers)Journal of Medicinal Chemistry (3 papers)
- Partner nations
- BelgiumCzechiaBurkina Faso
In The Last Decade
Eric Van Quaquebeke
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 88
- Toxicology 76
- Biomaterials 230
- Pharmacology 126
- Molecular Biology 705
- Organic Chemistry 228
Countries citing papers authored by Eric Van Quaquebeke
This map shows the geographic impact of Eric Van Quaquebeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Van Quaquebeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Van Quaquebeke more than expected).
Fields of papers citing papers by Eric Van Quaquebeke
This network shows the impact of papers produced by Eric Van Quaquebeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Van Quaquebeke. The network helps show where Eric Van Quaquebeke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eric Van Quaquebeke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 130 | |
| 2 | Cardiotonic steroids: Revealed by cardiology, hoped for potential in oncology. | 2008 | 1 |
| 3 | 2008 | 46 | |
| 4 | Narciclasine displays potent and selective anti-tumor effects by impairing cancer cell migration through a phosphocofilin-mediated increase of actin stress fibers | 2008 | 1 |
| 5 | UNBS5162: a novel naphthalimide derivative with potent pro-autophagic effects in human cancer cells. | 2007 | 1 |
| 6 | UNBS5162 is a novel naphthalimide derivative that induces autophagy and senescence in human prostate cancer cells | 2007 | 4 |
| 7 | UNBS1450-mediated cMyc down-regulation and nucleolar targeting in carcinoma cells through over-expressed sodium pump alpha-1 subunit. | 2007 | 1 |
| 8 | 2007 | 258 | |
| 9 | 2007 | 139 | |
| 10 | 2007 | 121 | |
| 11 | Cardenolide mediated cMyc down-regulation in human cancer cell lines. | 2007 | 1 |
| 12 | 2007 | 1 | |
| 13 | UNBS3157, a new amonafide derivative with improved in vivo efficacy and decreased toxicity | 2006 | 2 |
| 14 | Cardenolides: old drugs with new applications in oncology. | 2006 | 1 |
| 15 | Cardenolide-mediated nucleolar disorganisation contributes therapeutic benefits in subcutaneous and orthotopic xenograft models of human refractory prostate cancers. | 2006 | 2 |
| 16 | 2006 | 118 | |
| 17 | 2006 | 96 | |
| 18 | The binding of the UNBS1450 cardenolide to the sodium pump in human glioblastoma (GBM) cells dramatically impairs both their migration and proliferation properties. | 2006 | 2 |
| 19 | Cardenolide-related UNBS1450 compound target the Src kinase in the Na+/K+-ATPase signalosome and exert potent in vitro and in vivo anti-tumor activities in experimental human glioblastomas | 2005 | 2 |
| 20 | 2005 | 140 |
About Eric Van Quaquebeke
Eric Van Quaquebeke is a scholar working on Toxicology, Biomaterials and Pharmacology, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Phytochemical Studies and Bioactivities (7 papers), Phytochemistry and Bioactive Compounds (6 papers), Cancer therapeutics and mechanisms (5 papers), Steroid Chemistry and Biochemistry (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Ion Transport and Channel Regulation (3 papers), Natural product bioactivities and synthesis (3 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Toxicology (76 citations), Biomaterials (230 citations) and Pharmacology (126 citations). Eric Van Quaquebeke has collaborated with scholars based in Belgium, Czechia and Burkina Faso. Frequent co-authors include Róbert Kiss, Francis Darro, Tatjana Mijatovic, Janique Dewelle, Olivier Debeir, Bruno Delest, Mohamed El Yazidi, Véronique Mathieu, Jean‐François Gaussin and Patrick Dumont. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, Journal of Medicinal Chemistry, Neoplasia and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.